Acromegaly & Gigantism Prevalence to Grow, According to DelveInsight Study Published at MarketPublishers.com
02 May 2017 • by Natalie Aster
LONDON – Acromegaly represents a serious and rare hormonal disorder that is caused by the excessive growth hormone (aka GH) in the adults’ blood. Middle-aged women and men mostly suffer from the condition.
The prevalent cases of acromegaly across 7 major markets (the US, Spain, Germany, the UK, and more) are forecast to increase at a CAGR of around 0.7% over the period 2013-2023.
Gigantism makes up the impressive production of GH in kids. It is very rare and results into the exaggerated growth of bones along with the abnormal increase in height.
This disease is set to grow at a 2% CAGR in 6 major markets (France, Germany, the US, and Spain, to name a few).
Cutting-edge research report “Acromegaly and Gigantism- Epidemiology Forecast To 2023” drawn up by DelveInsight offers comprehensive examination of the global acromegaly and gigantism market. The study starts with an all-round overview of the conditions.
It sheds light on causes of these diseases, their signs and symptoms, covers risk factors, and pathophysiology. The report proceeds with a discussion of the diagnosis and treatment. The research study throws light on the epidemiology issues.
It canvasses treatment options, too. The research report scrutinizes major markets (see the ones mentioned above) and includes forecast figures through 2023.
Reasons to Buy:
- build up a full picture of the global market for acromegaly and gigantism;
- see which trends and developments shape the today’s marketplace;
- find out which forces drive and restrain the global space;
- learn how the market is set to develop in the offing.
More in-demand research report by DelveInsight are available at its page.